| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 679287 | Null | 0.0414190425892865 | 0.36474095 |
| NSC 683662 | 2-Azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaene- 3,20,22-trione, 9-[[(amino)carbonyl]oxy]-8,14-dimethoxy- 4,10,12,16-tetramethyl-13-[2-(dimethylamino)-1-oxoethoxy]-19-[(2-propenyl)amino]-, stereo | 0.0414190425892865 | -0.057755945 |
| NSC 685005 | Null | 0.0414190425892865 | 0.30727693 |
| NSC 691577 | Null | 0.0414190425892865 | 0.11925478 |
| NSC 694000 | 2-Butenedioic acid, (E)-, 2-[3-[[[[2-(acetyloxy)ethoxy] methyl]-3H-1,2,3-triazol-4-yl]methyl]- 1,2,3,4-tetrahydro-5-methyl-2,4-dioxo-1-pyrimidinyl]-,diethyl ester | 0.0414190425892865 | 0.2943326 |
| NSC 694002 | 2-Butenedioic acid, (E)-, 2-[3-[[[4-(acetyloxy)butyl]- 3H-1,2,3-triazol-4-yl]methyl]-1,2,3,4-tetrahydro-5-methyl-2,4-dioxo-1-pyrimidinyl]-, diethyl ester | 0.0414190425892865 | 0.28716574 |
| NSC 697189 | Null | 0.0414190425892865 | 0.38404606 |
| NSC 702158 | 7-epi-3,4-bis-nor-dolastatin 11 | 0.0414190425892865 | 0.21375016 |
| NSC 716354 | Null | 0.0414190425892865 | 0.21869552 |
| NSC 718185 | Null | 0.0414190425892865 | 0.30144892 |